TPDB

3D PDB MODEL

Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

TPDB ID TPDB91982

Peptide_Name

CA-MA3

Activity

Antibacterial Anticancer Toxicity

Activity_category_statistics

Anti-infective peptides Cancer-related peptides Toxicity and safety peptides

Database_Source

AntiBP3 Peptipedia AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF

Sequence_Type

standard

Has_Modification No

Description A 20-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from AntiBP3, Peptipedia, AntiCP 2.0, and other sources, with an available 3D structural model.

Modification

C-terminal: Amidation

Sequence

KWKLFKKIGPGKFLHSAKKF-NH2

FASTA

>TPDB91982|Antibacterial;Anticancer;Toxicity|length=20
KWKLFKKIGPGKFLHSAKKF-NH2

Formula C119H186N30O22

Absent Amino Acids RNDCEQMTYV

Common Amino Acids K

Mass 2388.97

PI 11.29

Basic Residues 8

Acidic Residues 0

Hydrophobic Residues 8

Net Charge +7

Boman Index 1.65

Hydrophobicity -0.615

Aliphatic Index 63.50

Half Life

Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min

Extinction Coefficient Cystines 5500

Absorbance 280nm 230.22

Polar Residues 1

number

1

A

0

R

0

N

0

D

0

C

0

E

0

Q

2

G

1

H

1

I

2

L

7

K

0

M

3

F

1

P

1

S

0

T

1

W

0

Y

0

V

Amino Acid Distribution

A: 1 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 2 H: 1 I: 1 L: 2 K: 7 M: 0 F: 3 P: 1 S: 1 T: 0 W: 1 Y: 0 V: 0

Length

20

Formula

C119H186N30O22

Mass

2388.97

PI

11.29

Net Charge

+7

Boman Index

1.65

Hydrophobicity

-0.615

C_terminal_Modification

Amidation

Chirality

L

Linear_or_Cyclic

Linear

N_terminal_Modification

Free

Nature

Antibacterial

Origin

Ceropin-Magainin hybrid peptides

Evidence 1 Activity

Activity

Activity Endpoint IC50

Activity Raw

IC50=>100 µM

Detail Source Activity Anticancer

Activity Measurement >100 µM

Target

Cancer Type Leukemia Cancer

Cell Line K-562

Tissue Affected Blood

Assay & Model

Assay MTT/MTS assay

Testing Time 72-h

Source & Reference

Database Source CancerPPD 2.0 dbACP SATPdb

Source CancerPPD2

Year 2000

Other

Source Activity Label	Source Definition
Anticancer	CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.

Evidence 2 Activity

Activity

Activity Endpoint IC50

Activity Raw

IC50=>100 µM

Detail Source Activity Anticancer

Activity Measurement >100 µM

Target

Cancer Type Lung Cancer

Cell Line A-549

Tissue Affected Lung

Assay & Model

Assay MTT/MTS assay

Testing Time 72-h

Source & Reference

Database Source CancerPPD 2.0 dbACP SATPdb

Source CancerPPD2

Year 2000

Evidence 3 Activity

Activity

Activity Endpoint IC50

Activity Raw

IC50=75 µM

Detail Source Activity Anticancer

Activity Measurement 75 µM

Target

Cancer Type Blood Cancer

Cell Line Jurkat

Tissue Affected Blood

Assay & Model

Assay MTT/MTS assay

Testing Time 72-h

Source & Reference

Database Source CancerPPD 2.0 dbACP SATPdb

Source CancerPPD2

Year 2000

Evidence 4 Activity

Activity

Activity Endpoint IC50

Activity Raw

IC50=>100 µM

Detail Source Activity Anticancer

Activity Measurement >100 µM

Target

Cancer Type Breast Cancer

Cell Line MDA-MB-361

Tissue Affected Breast

Assay & Model

Assay MTT/MTS assay

Testing Time 72-h

Source & Reference

Database Source CancerPPD 2.0 dbACP SATPdb

Source CancerPPD2

Year 2000